Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2020

01-12-2020 | Metastasis | Thoracic Oncology

Lymph Node Metastasis and Recurrences from Esophageal Squamous Cell Carcinoma in Patients with Previous Gastrectomy

Authors: Hiroshi Miyata, MD, Keijirou Sugimura, MD, Naoki Shinno, MD, Hisashi Hara, MD, Kazuyoshi Yamamoto, MD, Takeshi Omori, MD, Naotsugu Haraguchi, MD, Junichi Nishimura, MD, Masayoshi Yasui, MD, Daisaku Yamada, MD, Hiroshi Wada, MD, Kei Asukai, MD, Hidenori Takahashi, MD, Masayuki Ohue, MD, Masahiko Yano, MD

Published in: Annals of Surgical Oncology | Issue 13/2020

Login to get access

Abstract

Background

Esophageal cancer patients sometimes have a history of previous gastrectomy. To determine whether we should resect or preserve the remnant stomach, we need to understand the frequency and sites of abdominal lymph node (LN) metastasis from esophageal cancer after gastrectomy.

Patients and Methods

In 46 patients with thoracic esophageal squamous cell carcinoma (ESCC) who had a history of previous gastrectomy due to gastric cancer (n = 20) or benign disease (n = 26), the frequency and sites of any LN metastasis including LN metastasis at surgery and LN recurrence were investigated. The factors associated with abdominal LN metastasis were also examined.

Results

The incidence of metastasis to cervical, mediastinal, and abdominal LNs at surgery was 10.8%, 30.4%, and 30.4%, respectively. The incidence of abdominal LN recurrence was 6.5%. Of 46 patients, 16 patients (34.8%) had any abdominal LN metastasis, including abdominal LN metastasis at surgery or abdominal LN recurrence. There was no significant difference in the incidence of any abdominal LN metastasis between the gastric cancer group and the benign disease group (25.0% vs. 42.3%, p = 0.222). Clinically, nodal status was identified as the only independent factor associated with the occurrence of any abdominal LN metastasis, although neither tumor location nor the reason for gastrectomy was.

Conclusions

The present study showed that the incidence of abdominal LN metastasis from ESCC after gastrectomy was not necessarily low, regardless of the tumor location and the reason for previous gastrectomy. This result suggests that gastrectomy should not be omitted easily in ESCC patients after previous gastrectomy.
Literature
1.
go back to reference Shearman DJ, Arnott SJ, Finlayson ND, Pearson JG. Carcinoma of the oesophagus after gastric surgery. Lancet. 1970;1:581–582.CrossRef Shearman DJ, Arnott SJ, Finlayson ND, Pearson JG. Carcinoma of the oesophagus after gastric surgery. Lancet. 1970;1:581–582.CrossRef
2.
go back to reference Macdonald JB, Waissbluth JG, Langman MJ. Carcinoma of the oesophagus and gastric surgery. Lancet. 1971;1:19–20.CrossRef Macdonald JB, Waissbluth JG, Langman MJ. Carcinoma of the oesophagus and gastric surgery. Lancet. 1971;1:19–20.CrossRef
3.
go back to reference Maeta M, Koga S, Andachi H, Yoshioka H, Wakatsuki T. Esophageal cancer developed after gastrectomy. Surgery. 1986;99:87–91.PubMed Maeta M, Koga S, Andachi H, Yoshioka H, Wakatsuki T. Esophageal cancer developed after gastrectomy. Surgery. 1986;99:87–91.PubMed
4.
go back to reference Kato H, Tachimori Y, Watanabe H. Surgical treatment for thoracic esophageal carcinoma in patients after gastrectomy. J Surg Oncol. 1992;51:94–99.CrossRef Kato H, Tachimori Y, Watanabe H. Surgical treatment for thoracic esophageal carcinoma in patients after gastrectomy. J Surg Oncol. 1992;51:94–99.CrossRef
5.
go back to reference Kuwano H, Matsuda H, Nagamatsu M, et al. Occurrence of esophageal carcinoma after gastrectomy. J Surg Oncol. 1989;41:77–80.CrossRef Kuwano H, Matsuda H, Nagamatsu M, et al. Occurrence of esophageal carcinoma after gastrectomy. J Surg Oncol. 1989;41:77–80.CrossRef
6.
go back to reference Tachibana M, Abe S, Yoshimura H, et al. Squamous cell carcinoma of the esophagus after partial gastrectomy. Dysphagia. 1995;10:49–52.CrossRef Tachibana M, Abe S, Yoshimura H, et al. Squamous cell carcinoma of the esophagus after partial gastrectomy. Dysphagia. 1995;10:49–52.CrossRef
7.
go back to reference Alexandrou A, Davis PA, Law S, et al. Esophageal cancer in patients with a history of distal gastrectomy. Arch Surg. 2002;137:1238–1242.CrossRef Alexandrou A, Davis PA, Law S, et al. Esophageal cancer in patients with a history of distal gastrectomy. Arch Surg. 2002;137:1238–1242.CrossRef
8.
go back to reference Wada H, Doki Y, Nishioka K, et al. Clinical outcome of esophageal cancer patients with history of gastrectomy. J Surg Oncol. 2005;89:67–74.CrossRef Wada H, Doki Y, Nishioka K, et al. Clinical outcome of esophageal cancer patients with history of gastrectomy. J Surg Oncol. 2005;89:67–74.CrossRef
9.
go back to reference Nakanishi K, Daiko H, Kato F, et al. Efficacy of preserving the residual stomach in esophageal cancer patients with previous gastrectomy. Gen Thorac Cardiovasc Surg. 2019;67:470–478.CrossRef Nakanishi K, Daiko H, Kato F, et al. Efficacy of preserving the residual stomach in esophageal cancer patients with previous gastrectomy. Gen Thorac Cardiovasc Surg. 2019;67:470–478.CrossRef
10.
go back to reference Jun W, Wei W, Weibing W, et al. Clinical outcome of using gastric remnant or jejunum or colon conduit in surgery for esophageal carcinoma with previous gastrectomy. J Surg Oncol. 2017;115:729–737.CrossRef Jun W, Wei W, Weibing W, et al. Clinical outcome of using gastric remnant or jejunum or colon conduit in surgery for esophageal carcinoma with previous gastrectomy. J Surg Oncol. 2017;115:729–737.CrossRef
11.
go back to reference Poh M, Selber JC, Skoracki R, Walsh GL, Yu P. Technical challenges of total esophageal reconstruction using a supercharged jejunal flap. Ann Surg. 2011;253:1122–1129.CrossRef Poh M, Selber JC, Skoracki R, Walsh GL, Yu P. Technical challenges of total esophageal reconstruction using a supercharged jejunal flap. Ann Surg. 2011;253:1122–1129.CrossRef
12.
go back to reference Iwata N, Koike M, Kamei Y, et al. Antethoracic pedicled jejunum reconstruction with the supercharge technique for esophageal cancer. World J Surg. 2012;36:2622–2629.CrossRef Iwata N, Koike M, Kamei Y, et al. Antethoracic pedicled jejunum reconstruction with the supercharge technique for esophageal cancer. World J Surg. 2012;36:2622–2629.CrossRef
13.
go back to reference Blackmon SH, Correa AM, Skoracki R, et al. Supercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience. Ann Thorac Surg. 2012;94:1011–1104. Blackmon SH, Correa AM, Skoracki R, et al. Supercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience. Ann Thorac Surg. 2012;94:1011–1104.
14.
go back to reference Shirakawa Y, Naomoto Y, Noma K, et al. Colonic interposition and supercharge for esophageal reconstruction. Langenbecks Arch Surg. 2006;391:19–23.CrossRef Shirakawa Y, Naomoto Y, Noma K, et al. Colonic interposition and supercharge for esophageal reconstruction. Langenbecks Arch Surg. 2006;391:19–23.CrossRef
15.
go back to reference Klink CD, Binnebösel M, Schneider M, et al. Operative outcome of colon interposition in the treatment of esophageal cancer: a 20-year experience. Surgery. 2010;147:491–496.CrossRef Klink CD, Binnebösel M, Schneider M, et al. Operative outcome of colon interposition in the treatment of esophageal cancer: a 20-year experience. Surgery. 2010;147:491–496.CrossRef
16.
go back to reference Hamai Y, Hihara J, Emi M, Aoki Y, Okada M. Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery. Surg Today. 2012;42:342–350.CrossRef Hamai Y, Hihara J, Emi M, Aoki Y, Okada M. Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery. Surg Today. 2012;42:342–350.CrossRef
17.
go back to reference Mine S, Udagawa H, Tsutsumi K, et al. Colon interposition after esophagectomy with extended lymphadenectomy for esophageal cancer. Ann Thorac Surg. 2009;88:1647–1653.CrossRef Mine S, Udagawa H, Tsutsumi K, et al. Colon interposition after esophagectomy with extended lymphadenectomy for esophageal cancer. Ann Thorac Surg. 2009;88:1647–1653.CrossRef
18.
go back to reference Doki Y, Okada K, Miyata H, et al. Long-term and short-term evaluation of esophageal reconstruction using the colon or the jejunum in esophageal cancer patients after gastrectomy. Dis Esophagus. 2008;21:132–138.CrossRef Doki Y, Okada K, Miyata H, et al. Long-term and short-term evaluation of esophageal reconstruction using the colon or the jejunum in esophageal cancer patients after gastrectomy. Dis Esophagus. 2008;21:132–138.CrossRef
19.
go back to reference Watanabe M, Mine S, Nishida K, et al. Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy. Gen Thorac Cardiovasc Surg. 2016;64:457–463.CrossRef Watanabe M, Mine S, Nishida K, et al. Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy. Gen Thorac Cardiovasc Surg. 2016;64:457–463.CrossRef
20.
go back to reference Noguchi Y, Imada T, Abe S, et al. Lymphatic flow of the remnant stomach. Nihon Geka Gakkai Zasshi. 1988;89:852–862.PubMed Noguchi Y, Imada T, Abe S, et al. Lymphatic flow of the remnant stomach. Nihon Geka Gakkai Zasshi. 1988;89:852–862.PubMed
21.
go back to reference Miyata H, Sugimura K, Yamasaki M, et al. Clinical impact of the location of lymph node metastases after neoadjuvant chemotherapy for middle and lower thoracic esophageal cancer. Ann Surg Oncol. 2019;26:200–208.CrossRef Miyata H, Sugimura K, Yamasaki M, et al. Clinical impact of the location of lymph node metastases after neoadjuvant chemotherapy for middle and lower thoracic esophageal cancer. Ann Surg Oncol. 2019;26:200–208.CrossRef
22.
go back to reference Miyata H, Sugimura K, Motoori M, et al. Clinical implications of conversion surgery after induction therapy for T4b thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2019;26:4737–4743.CrossRef Miyata H, Sugimura K, Motoori M, et al. Clinical implications of conversion surgery after induction therapy for T4b thoracic esophageal squamous cell carcinoma. Ann Surg Oncol. 2019;26:4737–4743.CrossRef
23.
go back to reference Tachimori Y, Ozawa S, Numasaki H, et al. Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus. 2016;13:1–7.CrossRef Tachimori Y, Ozawa S, Numasaki H, et al. Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus. 2016;13:1–7.CrossRef
24.
go back to reference Udagawa H, Ueno M, Shinohara H, et al. The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol. 2012;106:742–747.CrossRef Udagawa H, Ueno M, Shinohara H, et al. The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol. 2012;106:742–747.CrossRef
25.
go back to reference Miyata H, Yamasaki M, Makino T, et al. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy. J Surg Oncol. 2015;112:60–65.CrossRef Miyata H, Yamasaki M, Makino T, et al. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy. J Surg Oncol. 2015;112:60–65.CrossRef
26.
go back to reference Yamamoto K, Takiguchi S, Miyata H, et al. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery. 2010;148:31–38.CrossRef Yamamoto K, Takiguchi S, Miyata H, et al. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery. 2010;148:31–38.CrossRef
27.
go back to reference Takiguchi S, Takata A, Murakami K, et al. Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy. Gastric Cancer. 2014;17:200–205.CrossRef Takiguchi S, Takata A, Murakami K, et al. Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy. Gastric Cancer. 2014;17:200–205.CrossRef
28.
go back to reference Miyata H, Sugimura K, Motoori M, et al. Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus. Surgery. 2019;166:1033–1040.CrossRef Miyata H, Sugimura K, Motoori M, et al. Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus. Surgery. 2019;166:1033–1040.CrossRef
29.
go back to reference Akutsu Y, Kato K, Igaki H, et al. The prevalence of overall and initial lymph node metastases in clinical T1N0 thoracic esophageal cancer: from the results of JCOG0502, a prospective multicenter study. Ann Surg. 2016;264:1009–1015.CrossRef Akutsu Y, Kato K, Igaki H, et al. The prevalence of overall and initial lymph node metastases in clinical T1N0 thoracic esophageal cancer: from the results of JCOG0502, a prospective multicenter study. Ann Surg. 2016;264:1009–1015.CrossRef
30.
go back to reference Schlottmann F, Barbetta A, Mungo B, Lidor AO, Molena D. Identification of the lymphatic drainage pattern of esophageal cancer with near-infrared fluorescent imaging. J Laparoendosc Adv Surg Tech A. 2017;27:268–271.CrossRef Schlottmann F, Barbetta A, Mungo B, Lidor AO, Molena D. Identification of the lymphatic drainage pattern of esophageal cancer with near-infrared fluorescent imaging. J Laparoendosc Adv Surg Tech A. 2017;27:268–271.CrossRef
31.
go back to reference Hachey KJ, Gilmore DM, Armstrong KW, et al. Safety and feasibility of near-infrared image-guided lymphatic mapping of regional lymph nodes in esophageal cancer. J Thorac Cardiovasc Surg. 2016;152:546–554.CrossRef Hachey KJ, Gilmore DM, Armstrong KW, et al. Safety and feasibility of near-infrared image-guided lymphatic mapping of regional lymph nodes in esophageal cancer. J Thorac Cardiovasc Surg. 2016;152:546–554.CrossRef
Metadata
Title
Lymph Node Metastasis and Recurrences from Esophageal Squamous Cell Carcinoma in Patients with Previous Gastrectomy
Authors
Hiroshi Miyata, MD
Keijirou Sugimura, MD
Naoki Shinno, MD
Hisashi Hara, MD
Kazuyoshi Yamamoto, MD
Takeshi Omori, MD
Naotsugu Haraguchi, MD
Junichi Nishimura, MD
Masayoshi Yasui, MD
Daisaku Yamada, MD
Hiroshi Wada, MD
Kei Asukai, MD
Hidenori Takahashi, MD
Masayuki Ohue, MD
Masahiko Yano, MD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08734-w

Other articles of this Issue 13/2020

Annals of Surgical Oncology 13/2020 Go to the issue